New Issue: Orbital Catastrophe Ahead? Read Now

Psoriasis Linked to Protection from HIV-1

Many psoriasis patients have the same gene variants as people who are not significantly affected by an HIV-1 infection. Charles Q. Choi reports

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

Psoriasis is an autoimmune disease—the immune system mistakenly attacks its own body, causing red, itchy, scaly patches on the skin. But there may be a hidden upside. People with psoriasis are more likely to have gene variants that protect them against the effects of HIV-1.

Researchers had noticed that some psoriasis patients had the same gene variants as people known as "HIV-1 controllers." Such people have HIV-1, but they naturally maintain low levels of the virus and generally do not develop any obvious symptoms of AIDS.

To investigate further, scientists looked at more than 1,700 psoriasis patients and nearly 3,600 people who don’t have it. People who have psoriasis were significantly more likely to have the gene variants known to defend against HIV-1 and delay its progression to AIDS. The study is in the journal Public Library of Science Genetics. [Haoyan Chen et al.,"Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease"]


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


These findings suggest that psoriasis is a malfunction of antiviral gene variants that ordinarily protect us against disease. Further research could help us understand why autoimmune diseases develop, and give researchers new tools for treating HIV.

—Charles Q. Choi

[The above text is a transcript of this podcast.]
 

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe